Senhwa Biosciences, Inc. (TPEX:6492)

Senhwa Biosciences Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	May 12, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	2,982	3,880	4,540	5,140	9,329	20,164
Market Cap Growth	-13.61%	-14.54%	-11.69%	-44.90%	-53.73%	319.76%
Enterprise Value	2,034	2,808	3,169	3,440	7,207	17,707
Last Close Price	33.45	43.50	50.90	58.00	104.00	225.00
Forward PE	-	-	-	-	9.84	142.41
PS Ratio	2981.92	3879.59	4539.57	5140.42	16962.14	32680.84
PB Ratio	3.09	3.78	3.45	3.19	4.74	8.67
P/TBV Ratio	3.09	3.78	3.45	3.19	4.74	8.67
EV/Sales Ratio	-	2807.58	3169.23	3440.18	13103.10	28698.36
Debt / Equity Ratio	0.01	0.02	0.01	0.01	0.01	0.01
Asset Turnover	0.00	0.00	0.00	0.00	0	0
Quick Ratio	43.22	33.01	31.00	49.40	24.81	38.76
Current Ratio	43.57	33.29	31.15	49.69	24.87	38.90
Return on Equity (ROE)	-26.27%	-25.06%	-20.22%	-19.52%	-15.33%	-22.50%
Return on Assets (ROA)	-16.63%	-15.75%	-12.88%	-11.98%	-9.71%	-13.80%
Return on Capital (ROIC)	-16.87%	-16.16%	-13.15%	-12.31%	-10.00%	-14.12%
Earnings Yield	-9.79%	-7.57%	-6.53%	-6.80%	-3.53%	-1.76%
FCF Yield	-	-7.63%	-6.59%	-7.79%	-3.22%	-1.35%
Buyback Yield / Dilution	-	-	0.00%	0.50%	-13.49%	-6.06%

Updated Mar 17, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.